Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: ion channel and GABA A modulators - Saniona

Drug Profile

Research programme: ion channel and GABA A modulators - Saniona

Alternative Names: AN 346; AN 363; AN 470; AN 761; AN-726; NS9283; NSD-708; NSD-761; NSD-847; NSD-867

Latest Information Update: 02 Oct 2021

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator GlaxoSmithKline; NeuroSearch
  • Developer Saniona
  • Class Analgesics; Anti-inflammatories; Antidementias; Antipruritics; Neuroprotectants
  • Mechanism of Action Alpha4beta2 nicotinic receptor modulators; Alpha7 nicotinic acetylcholine receptor agonists; GABA A alpha 2 receptor modulators; GABA A alpha 3 receptor modulators; GABA A receptor modulators; GABA modulators; Intermediate conductance calcium activated potassium channel modulators; Ion channel modulators; Small conductance calcium activated potassium channel modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Alzheimer's disease; CNS disorders; Dyskinesias; Inflammatory bowel diseases; Neuropathic pain; Schizophrenia

Most Recent Events

  • 28 Feb 2020 Discontinued - Preclinical for Alzheimer's disease in Denmark (unspecified route)
  • 28 Feb 2020 Discontinued - Preclinical for CNS disorders in Denmark (unspecified route)
  • 28 Feb 2020 Discontinued - Preclinical for Dyskinesias in Denmark (unspecified route)
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top